Shares in ReNeuron, which won regulatory approval for the trial in January and had initially hoped to launch it in the second quarter of 2010, rose more than 18 percent on the news.
Editor: How nice for the investors. Here's more, showing that the cells are from aborted babies --
A neurosurgeon at Southern General Hospital in Glasgow, Scotland, plans to drill a hole in a patient’s skull, insert a needle and inject 2 million stem cells from ReNeuron Group into his brain early next year. The patient is the first of 12 men disabled by strokes who expect to receive from 2 million to 20 million stem cells grown from the brain of an aborted 12-week-old fetus. The men would be studied for two years to see if the cells help the brain repair damage, without causing further harm. Bloomberg
No comments:
Post a Comment